Results 41 to 50 of about 24,464,352 (186)

KPC-derived organoid tumor histopathology features.

open access: yes, 2020
KPC-derived organoid tumor stained for hyaluronic acid (A), pimonidazole (B), collagen (green) and Meca32 (red) (C). Co-staining of pimonidazole (green) and Meca-32 (red) (D) showing vessels present in both oxic and hypoxic tissue. Black scale bar = 5 mm.
John L. Humm (8720559)   +6 more
core   +1 more source

First Report of KPC-2 Carbapenemase-Producing Klebsiella pneumoniae in Japan [PDF]

open access: yesAntimicrobial Agents and Chemotherapy, 2014
ABSTRACT We investigated a novel Japanese isolate of sequence type 11 (ST11), the Klebsiella pneumoniae carbapenemase-2 (KPC-2)-producing K. pneumoniae strain Kp3018, which was previously obtained from a patient treated at a Brazilian hospital.
Ryoichi, Saito   +14 more
openaire   +2 more sources

Prevalence of blaKPC-2, blaKPC-3 and blaKPC-30—Carrying Plasmids in Klebsiella pneumoniae Isolated in a Brazilian Hospital

open access: yesPathogens, 2021
Klebsiella pneumoniae carbapenemase (KPC) actively hydrolyzes carbapenems, antibiotics often used a last-line treatment for multidrug-resistant bacteria. KPC clinical relevance resides in its widespread dissemination.
Letícia B. Migliorini   +10 more
doaj   +1 more source

Identification of carbapenemase KPC-2 encoding plasmids among environmental Enterobacteriaceae

open access: yes, 2022
Pojava rezistentnih sojeva Enterobacteriaceae posljedica je nerijetke uporabe karbapenemskih antibiotika u kliničkoj praksi. Karbapenemaze hidroliziraju karbapenemske antibiotike, a geni koji ih kodiraju su povezani s visokorizičnim klonovima i šire se
Bellulovich, Ema
core   +2 more sources

Rapid Detection of blaKPC-9 Allele from Clinical Isolates

open access: yesPathogens, 2021
The emergence of Klebsiella pneumoniae carbapenemase (KPC) nosocomial outbreaks related to specific blaKPC gene variants dictates the need for applicable diagnostic methods for allele discrimination.
Konstantina Gartzonika   +3 more
doaj   +1 more source

Relebactam is a potent inhibitor of the kpc-2 -lactamase and restores imipenem susceptibility in kpc-producing enterobacteriaceae [PDF]

open access: yes, 2018
The imipenem-relebactam combination is in development as a potential treatment regimen for infections caused by Enterobacteriaceae possessing complex -lactamase backgrounds. Relebactam is a -lactamase inhibitor that possesses the diazabicyclooctane core,
Alsop J.   +9 more
core   +1 more source

Resistance Phenotype and Molecular Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae Isolated from Nanjing Children’s Hospital in Jiangsu Province, China

open access: yesInfection and Drug Resistance, 2022
Guixiang Tao,1 Hua Tan,2 Jingjing Ma,1 Qian Chen1 1Institute of Pediatrics, Children’s Hospital of Nanjing Medical University, Nanjing, People’s Republic of China; 2Department of Laboratory Medicine, Children’s Hospital of Nanjing Medical University ...
Tao G, Tan H, Ma J, Chen Q
doaj  

Identification of Two Novel Carbapenemase-Encoding Hybrid Plasmids Harboring blaNDM-5 and blaKPC-2 in a Clinical ST11-KL47 Klebsiella pneumoniae

open access: yesInfection and Drug Resistance, 2023
Weiqiang Xiao,1,* Xiaokun Wang,1,* Yuanye Qu,1 Mingyue Sun,1 Yanmin Chang,1 Wenjiao Li,1 Yong Shen,1,2 Xiufang Shi,3 Min Jing,1 Qingxia Xu1,4 1Department of Clinical Laboratory, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou ...
Xiao W   +9 more
doaj  

Characterization of the two tandem repeats for the KPC-2 core structures on a plasmid from hospital-derived Klebsiella pneumoniae

open access: yesScientific Reports, 2023
Today, Klebsiella pneumoniae strains are sophisticatedly associated with the transmission of KPC, and ST11 clones carrying KPC-2 are an important target for anti-infective clinical therapy, posing a very high threat to patients.
Liman Ma   +3 more
doaj   +1 more source

The Structural Role of N170 in Substrate‐Assisted Deacylation in KPC‐2 β‐Lactamase

open access: yesAngewandte Chemie, 2023
AbstractThe amino acid substitutions in Klebsiella pneumoniae carbapenemase 2 (KPC‐2) that have arisen in the clinic are observed to lead to the development of resistance to ceftazidime‐avibactam, a preferred treatment for KPC bearing Gram‐negative bacteria.
Diksha Parwana   +7 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy